Zu den Deals
Gesundheitswesen

InNeuroCo has been acquired by Integer

The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).

Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.

With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.

Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).

Services
M&A sell-side
Parteien
„InNeuroCo’s founders have enjoyed a long-standing history of success with the Oaklins TM healthcare team. When we began contemplating a transaction for InNeuroCo, it was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate the team’s tireless dedication and thoughtful approach.“

Marc Litzenberg

President and CEO, InNeuroCo

Sprechen Sie mit dem Deal-Team

James McLaren

James McLaren

Geschäftsführer
New York, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme
Michael S. Goldman

Michael S. Goldman

Geschäftsführer
New York, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme
John Dean

John Dean

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme
Bradley S. Goldstein

Bradley S. Goldstein

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme
Ariel Fieldman

Ariel Fieldman

Associate
New York, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme
Matthew Halbig

Matthew Halbig

Analyst
Atlanta, Vereinigte Staaten
Oaklins TM Capital
Profil ansehen Kontaktaufnahme

Relevante Transaktionen

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Gesundheitswesen

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Weitere Informationen
Afric Phar has been acquired by Pharma Capital
Gesundheitswesen

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Weitere Informationen
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Gesundheitswesen

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Weitere Informationen